Contrary to its canonical role in anti-tumor immunity, recent evidence suggests that a heightened tumor-intrinsic IFN response can predict adverse outcomes following immune checkpoint inhibition (ICI), potentially fostering immune tolerance and metastasis [19, 20]. This evidence concerns the gene IFNA1 and neoplasm.